Clinical Trial Update: A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined AL2846 capsule with Gemzar (gemcitabine) was studied in Phase 1/2 for advanced pancreatic cancer; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AL2846
• Gemzar (gemcitabine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED